CTRI/2024/07/070918
Not Yet Recruiting
Phase 2
Palliative radiotherapy with or without concurrent chemotherapy for dysphagia in esophageal cancer- a randomised prospective clinical study.
Post Graduate Institute of medical Education and Research0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified
- Sponsor
- Post Graduate Institute of medical Education and Research
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Biopsy proven Squamous cell carcinoma esophagus.
- •Willing to participate
- •Not suitable for definitive chemoradiation therapy.
- •Advanced stage disease
- •KPS more than 70\.
Exclusion Criteria
- •Pregnant females.
- •Early stage disease.
- •Not willing to participate
- •Patient not fit for chemotherapy due to comorbidities
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of palliative radiotherapy combined with Zoledronic Acid Hydrate for metastatic bone tumor from renal cell carcinomaRenal cancerJPRN-UMIN000007836Shizuoka Cancer Center Japanese Radiation Oncology Study Group30
Not Yet Recruiting
Phase 3
Chemoradiotherapy versus Radiotherapy alone in post-operative locally advanced oral cavity cancerCTRI/2024/06/069157Department Of Radiotherapy and Radiation medicine
Active, Not Recruiting
Phase 1
ABiochemically-relapsing prostate adenocarcinoma following radical prostatectomy.MedDRA version: 14.1 Level: LLT Classification code 10001186 Term: Adenocarcinoma of prostate System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-004831-30-FRICANCER43
Recruiting
Phase 2
Radiotherapy to all involved sites in advanced prostate cancerHealth Condition 1: C61- Malignant neoplasm of prostateCTRI/2022/10/046239Intramural Tata memorial Centre
Unknown
Phase 3
A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial-This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.Deep regional hyperthermiaThermotron-RF8radiation therapychemotherapyTCTR20180711002Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy90